Ellis Investment Partners’s Sanofi SNY Stock Holding History

Ellis Investment Partners’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-82	Closed	-$3K	–	654
2022 Q3	$3K	Sell	82 -82	-50%	-$3.65K	﹤0.01%	710
2022 Q2	$8K	Hold	164	–	–	﹤0.01%	620
2022 Q1	$8K	Hold	164	–	–	﹤0.01%	652
2021 Q4	$8K	Sell	164 -50	-23%	-$2.47K	﹤0.01%	649
2021 Q3	$10K	Sell	214 -60	-22%	-$3.05K	﹤0.01%	609
2021 Q2	$14K	Hold	274	–	–	﹤0.01%	563
2021 Q1	$14K	Hold	274	–	–	﹤0.01%	537
2020 Q4	$13K	Hold	274	–	–	﹤0.01%	534
2020 Q3	$13K	Hold	274	–	–	﹤0.01%	532
2020 Q2	$14K	Hold	274	–	–	0.01%	497
2020 Q1	$11K	Buy	274 +224	+448%	+$10.7K	0.01%	477
2019 Q4	$2K	Hold	50	–	–	﹤0.01%	644
2019 Q3	$2K	Buy	+50	New	+$2.16K	﹤0.01%	668

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Ellis Investment Partners's SNY Position: Q4 2022 in Review

Ellis Investment Partners sold out of Sanofi (SNY) in Q4 2022, closing a stake of 82 shares — an estimated $3K sold.

Ellis Investment Partners first reported a position in SNY in Q3 2019 and held it in 13 quarters. The position peaked at $14K in Q2 2021. 643 funds tracked by Wall St. Rank hold SNY as of Q4 2022.

Ellis Investment Partners reported no remaining Sanofi position as of Q4 2022 after selling out during the quarter.
Ellis Investment Partners sold 82 Sanofi shares in Q4 2022, an estimated $3K.
Ellis Investment Partners first reported a position in Sanofi in Q3 2019 and held it in 13 quarters.
Ellis Investment Partners's Sanofi position peaked at $14K in Q2 2021.
643 funds tracked by Wall St. Rank held Sanofi as of Q4 2022.

Based on Ellis Investment Partners's 13F filing for Q4 2022, filed 31 Jan 2023.